Literature DB >> 24012659

β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.

Jing Tang1, Zhijie Li, Lan Lu, Chi Hin Cho.   

Abstract

β-Adrenoceptors are broadly distributed in various tissues of the body. Stress hormones regulate a panel of important physiological functions and disease states including cancer. Nicotine and its derivatives could stimulate the release of stress hormones from cancer cells, leading to the promotion of cancer development. β-Blockers have been widely used to control hypertension for decades. Recently, these agents could have significant implications in cancer therapy through blockade of adrenoceptors in tumour tissues. In this review, we summarize recent advancements about the influence of stress hormones, nicotine and β-adrenoceptors on cancer cell proliferation, apoptosis, invasion and metastasis, and also tumour vasculature normalization. Relevant signal pathways and potential value of β-blockers in the treatment of cancer are also discussed in this review.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; AC; AP1; Angiogenesis; BAD; BCL2-associated death protein; CREB; DR; EC; EPAC; FAK; GABA; GROα; HIF-1α; HRG; IL-6; MAPK; MMP; NF-κB; NNK; Nicotine; PDGF; PI3K; PKA; PVC; PlGF; STAT3; Stress hormones; TAM; TGF-β; Tumour progression; VEGF; activator protein 1; adenylyl cyclase; cAMP; cAMP response element binding protein; cyclic AMP; dopamine receptor; endothelial cells; exchange protein activated by adenylyl cyclase; focal adhesion kinase; growth-regulated oncogene alpha; histidine-rich glycoprotein; hypoxia-inducible factor-1; interleukin-6; matrix metalloproteinase; mitogen-activated protein kinase; nAChR; nicotinic acetylcholine receptors; nuclear factor-κB; p70S6 kinase; p70S6K; perivascular cell; phosphoinositide 3-kinase; placenta-derived growth factor; platelet-derived growth factor; protein kinase A; signal transducer and activator of transcription-3; transforming growth factor β; tumor associated macrophages; vascular endothelial growth factor; β-Adrenergic system; β-Adrenoceptors; β-Blockers; γ-aminobutyric acid

Mesh:

Substances:

Year:  2013        PMID: 24012659     DOI: 10.1016/j.semcancer.2013.08.009

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  60 in total

Review 1.  Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

2.  β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.

Authors:  Jessica M Wilson; Ellen Lorimer; Michael D Tyburski; Carol L Williams
Journal:  Cancer Biol Ther       Date:  2015-07-24       Impact factor: 4.742

3.  Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.

Authors:  Lois M Ramondetta; Wei Hu; Premal H Thaker; Diana L Urbauer; Gary B Chisholm; Shannon N Westin; Yunjie Sun; Pedro T Ramirez; Nicole Fleming; Sunil K Sahai; Alpa M Nick; Jesusa M G Arevalo; Thomas Dizon; Robert L Coleman; Steve W Cole; Anil K Sood
Journal:  Gynecol Oncol       Date:  2019-07-25       Impact factor: 5.482

Review 4.  β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors.

Authors:  Massimo Dal Monte; Maura Calvani; Maurizio Cammalleri; Claudio Favre; Luca Filippi; Paola Bagnoli
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

5.  Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1.

Authors:  John W Bullen; Irina Tchernyshyov; Ronald J Holewinski; Lauren DeVine; Fan Wu; Vidya Venkatraman; David L Kass; Robert N Cole; Jennifer Van Eyk; Gregg L Semenza
Journal:  Sci Signal       Date:  2016-05-31       Impact factor: 8.192

6.  Adrenoceptor modulators and cancer progression.

Authors:  Kazuyoshi Hirota
Journal:  J Anesth       Date:  2016-04-06       Impact factor: 2.078

Review 7.  The Role of β-Blockers in Melanoma.

Authors:  Vincenzo De Giorgi; Pierangelo Geppetti; Chiara Lupi; Silvia Benemei
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-03       Impact factor: 4.147

8.  Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Authors:  S Sud; C O'Callaghan; C Jonker; C Karapetis; T Price; N Tebbutt; J Shapiro; G Van Hazel; N Pavlakis; P Gibbs; M Jeffrey; L Siu; S Gill; R Wong; D Jonker; D Tu; R Goodwin
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

9.  Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.

Authors:  Federica Sereni; Massimo Dal Monte; Luca Filippi; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-19       Impact factor: 3.000

Review 10.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.